caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1942302823

Mirlia PolancoMD

EndocrinologySan Juan, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mirlia Polanco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.107361
Ferdinand Rivera Ortiz
Nephrology · San Juan, PR
28112
RENDON, WILFREDO2129
Lydia Rodriguez Ortiz
Endocrinology · San Juan, PR
2023
LABORATORIO CLINICO C L A INC1748
Laboratorio Clinico Borinquen, Inc
Clinical Laboratory · Caguas, PR
1627
Laboratorio Clinico Bairoa Inc
Clinical Laboratory · Caguas, PR
1636
Noel Colon De Leon
Anesthesiology · San Juan, PR
1523
Gilberto Rivera
Cardiology · San Juan, PR
1215
SEIN, ROBERTO1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
111
Unique beneficiaries
—
Total services
194
Distinct HCPCS
2
Medicare payment
$11K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 86 Endocrinology providers in PR — top quintile (cohort median 88).
PRESCRIBING · PART D · 2024
Total Rx claims
5,372
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
68
Brand share
62.7%
Top prescribed drugs
Levothyroxine Sodium1,247 claims
Rosuvastatin Calcium294 claims
Metformin Hcl227 claims
Atorvastatin Calcium216 claims
Sitagliptin Phosphate180 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.